Without it, theres no guarantee that compounded options will be absorbed or effective
The FTC alleges that as of early 2022, Southern Health Solutions, Inc., d/b/a Next Medical and NextMed, its founder, Robert Epstein, and CEO, Frank Leonardo III, sold telehealth weight-loss membership programs that allowed consumers access to medical providers who could prescribe GLP-1 drugs, but not much else
Heres a little bit more information about why we prefer Limitless Life to other vendors: Independent Quality Testing: Limitless Life offers products with a purity rating of 99% or greater
People who followed the slower increase had fewer side effects
A study examined samples from several different vendors and found that they contained unknown impurities ranging from 4.1 to 5.9%
announced it would discontinue developing danuglipron, an oral GLP-1 receptor agonist for chronic weight management